Life Sciences Cases To Watch In 2016

Law360, New York (December 24, 2015, 8:37 PM ET) -- Attorneys in the life sciences industry will be tracking cases on issues such as the approval path for biosimilar drugs and a circuit split on product-hopping in the coming year, making for a very busy 2016.



Here are six sets of life sciences cases that attorneys should be keeping their eye on in 2016.



Biosimilars Ruling Aftermath



Biosimilars litigation is “going to explode” in 2016, Irell & Manella LLP partner David Gindler said. At least four major cases are pending involving the Affordable Care Act's biosimilar...

To view the full article, register now.